Last reviewed · How we verify

NCT04967300

Measuring and Evaluating the Changes in Anxiety Levels of Children With Repetitive Sessions of Dental Treatments

Completed Last updated 19 July 2021
What this trial tests

trial testing Dental treatment in Dental Anxiety in 224 participants. Completed in 30 August 2020.

Timeline
1 March 2020
Primary endpoint
30 July 2020
30 August 2020

Quick facts

Lead sponsorErzincan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment224
Start date1 March 2020
Primary completion30 July 2020
Estimated completion30 August 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Erzincan University

Who can join

Adults 5 to 8, any sex, with Dental Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dental anxiety is defined as the fear of terrible events during dental treatment and the loss of control.Anxiety may be related to adaptation of the patient to external factors in environment, so the adaptation of the pediatric patient to the stimuli in the dental environment may affect the level of anxiety.The aim of the this study was to evaluate the relationship between sequential visits in dental treatments and dental anxiety levels of pediatric patients with anxiety scales and physiological measurements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dental treatment

Trials testing the same drug.

Other recruiting trials for Dental Anxiety

Currently open trials in the same condition.

Other Erzincan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04967300.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing